loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Zandelisib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Zandelisib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: 1401436-95-0, Zandelisib [inn], Zandelisib [usan], Pwt143, Acc-524, Pwt-143
    Molecular Formula
    C31H38F2N8O
    Molecular Weight
    576.7  g/mol
    InChI Key
    WPFUFWIHMYZXSF-UHFFFAOYSA-N
    FDA UNII
    8Z28M5SX0X
    Zandelisib is an orally bioavailable inhibitor of the delta isoform of phosphatidylinositide 3-kinase (PI3K), with potential antineoplastic activity. Upon oral administration, zandelisib selectively inhibits the delta isoform of PI3K and prevents the activation of the PI3K/AKT signaling pathway. This both decreases proliferation and induces cell death in PI3K-delta-overexpressing tumor cells. PI3K-delta plays a key role in the proliferation and survival of hematologic cancer cells. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells. PI3K, an enzyme often overexpressed in cancer cells, plays a crucial role in tumor cell regulation and survival.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
    2.1.2 InChI
    InChI=1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38)
    2.1.3 InChI Key
    WPFUFWIHMYZXSF-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F
    2.2 Other Identifiers
    2.2.1 UNII
    8Z28M5SX0X
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 1401436-95-0

    2. Zandelisib [inn]

    3. Zandelisib [usan]

    4. Pwt143

    5. Acc-524

    6. Pwt-143

    7. Pw-143

    8. 8z28m5sx0x

    9. 4-[2-(difluoromethyl)benzimidazol-1-yl]-n-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine

    10. 1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-1h-benzimidazol-1-yl)-n-(1,1-dimethyl-2-(2-(1-methyl-4-piperidinyl)phenyl)ethyl)-6-(4-morpholinyl)-

    11. 1,3,5-triazin-2-amine, 4-[2-(difluoromethyl)-1h-benzimidazol-1-yl]-n-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-

    12. 4-(2-(difluoromethyl)benzimidazol-1-yl)-n-(1,1-dimethyl-2-(2-(1-methyl-4-piperidyl)phenyl)ethyl)-6-morpholino-1,3,5-triazin-2-amine

    13. Zandelisib [jan]

    14. Unii-8z28m5sx0x

    15. Zandelisib [who-dd]

    16. Chembl4650214

    17. Schembl12936730

    18. Gtpl10627

    19. Ex-a5471

    20. Me-401; Pwt-143

    21. Who 11202

    22. Zinc148868634

    23. At32468

    24. Ac-35708

    25. Example 51 [wo2012135160a1]

    26. Hy-109198

    27. Cs-0119144

    28. A35 [wo2012135160a1]

    2.4 Create Date
    2012-11-19
    3 Chemical and Physical Properties
    Molecular Weight 576.7 g/mol
    Molecular Formula C31H38F2N8O
    XLogP35.7
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count8
    Exact Mass576.31366419 g/mol
    Monoisotopic Mass576.31366419 g/mol
    Topological Polar Surface Area84.2 Ų
    Heavy Atom Count42
    Formal Charge0
    Complexity855
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY